Oral Wegovy for obesity might be right for you if you're at least 18 years old, have a BMI of 30 or more, or have a BMI of at least 27 with one or more weight-related conditions like type 2 diabetes, high blood pressure, cholesterol issues, or sleep apnea
CagriSema CagriSema is an investigational fixed-dose combination of cagrilintide, a long-acting amylin analog, and semaglutide, a GLP-1 receptor agonist, co-administered once weekly and studied in Phase 3 trials for obesity and type 2 diabetes.
View our plans & pricing page for more detailed plan and pricing options
Pure Bio Labs PT-141 Spray is a research-grade peptide formulation intended exclusively for scientific studies involving physiological processes such as blood flow modulation and cellular function
However, tirzepatide typically ranges from $300 to $1,000 per month